Consistently, western blot analysis further revealed decreased expression of ATG, a reduced ratio of LC3-II to LC3-I, and increased SQSTM1 in breast cancer cells with TRPV2 knockdown (Fig. 4G-I). Here, TRPV2 is linked to breast cancer.